Abstract Sufficient quantity and quality of skeletal muscle is required to maintain lifespan and healthspan into older age. The concept of skeletal muscle programming/memory has been suggested to contribute to accelerated muscle decline in the elderly in association with early life stress such as fetal malnutrition. Further, muscle cells in vitro appear to remember the in vivo environments from which they are derived (e.g. cancer, obesity, type II diabetes, physical inactivity and nutrient restriction). Tumournecrosis factor alpha (TNF-a) is a pleiotropic cytokine that is chronically elevated in sarcopenia and cancer cachexia. Higher TNF-a levels are strongly correlated with muscle loss, reduced strength and therefore morbidity and earlier mortality. We have extensively shown that TNF-a impairs regenerative capacity in mouse and human muscle derived stem cells [Meadows et 
. We have also recently established an epigenetically mediated mechanism (SIRT1-histone deacetylase) regulating survival of myoblasts in the presence of TNF-a [Saini et al. (Exp Physiol 97(3):400-418, 2012) ]. We therefore wished to extend this work in relation to muscle memory of catabolic stimuli and the potential underlying epigenetic modulation of muscle loss. To enable this aim; C2C12 myoblasts were cultured in the absence or presence of early TNF-a (early proliferative lifespan) followed by 30 population doublings in the absence of TNF-a, prior to the induction of differentiation in low serum media (LSM) in the absence or presence of late TNF-a (late proliferative lifespan). The cells that received an early plus late lifespan dose of TNF-a exhibited reduced morphological (myotube number) and biochemical (creatine kinase activity) differentiation vs. control cells that underwent the same number of proliferative divisions but only a later life encounter with TNF-a. This suggested that muscle cells had a morphological memory of the acute early lifespan TNF-a encounter. Importantly, methylation of myoD CpG islands were increased in the early TNF-a cells, 30 population doublings later, suggesting that even after an acute encounter with TNF-a, the cells have the capability of retaining elevated methylation for at least 30 cellular divisions. Despite these fascinating findings, there were no further increases in myoD methylation or changes in its gene expression when these cells were exposed to a later TNF-a dose suggesting that this was not directly responsible for the decline in differentiation observed. In conclusion, data suggest that elevated myoD methylation is retained throughout muscle cells proliferative lifespan as result of early life TNF-a treatment and has implications for the epigenetic control of muscle loss.
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Introduction
Early evidence for the concept of skeletal muscle 'memory' has emerged from animal studies that investigated a phenomenon defined as 'fetal programming.' This notion referred to alterations in fetal growth and development in response to the prenatal environment having long term or permanent effects in later life. Original works 40 years ago, described early malnutrition during rat pregnancy reducing general cell numbers in the offspring (McLeod et al. 1972) . In skeletal muscle it was initially observed that restricted-maternal nutrition by 60 % of the normal energy consumed was found to alter expression of Insulin-like-growth factor II (IGF-II) in ewe foetuses during gestation (Brameld et al. 2000) . Since then, a wealth of evidence has suggested that both maternal carbohydrate and amino acid restriction leads to reduced fibre number and size (Fahey et al. 2005; Mallinson et al. 2007 ), altered protein synthetic signalling (Zhu et al. 2004 ) and even predisposes the offspring to obesity and type-II diabetes in later life (Samuelsson et al. 2008; Shelley et al. 2009; Zhu et al. 2006) . These studies are suggestive of a programming or 'memory' of the foetal environment in the skeletal muscle of the offspring. In humans it has also been demonstrated, through epidemiological studies, that fetal programming and malnutrition have an effect on musculoskeletal development and are associated with changes in body composition into older age (Patel et al., 2010 , Sayer and Cooper 2005 Sayer et al. 2004) . Importantly, reduced weight at birth is correlated with reduced grip strength and decreased muscle size (Funai et al. 2006; Gale et al. 2007; Inskip et al. 2006; Patel et al. 2010 Patel et al. , 2011 Patel et al. , 2014 Patel et al. , 2012 Sayer et al. 1998) . These factors are associated with increased risk of disability, morbidity and mortality later in life (Gale et al. 2007; Laukkanen et al. 1995; Rantanen 2003; Rantanen et al. 1999 Rantanen et al. , 2002 . The molecular mechanisms of such a phenomenon and the concept of skeletal muscle programming/memory, particularly in the regulation of adult skeletal muscle mass growth and loss following changes in anabolic/catabolic environments throughout the lifespan have not been directly investigated.
Studies into the modulators of skeletal muscle growth eluding to a cellular retention have recently been investigated. Most notably, 3 months of testosterone administration in mice enabled muscle growth accompanied by increased myonuclei number that was retained during subsequent testosterone withdrawal despite muscle loss. The subsequent increase in muscle cross-sectional area following 6 days of mechanical overload was 31 % in the animals that had received an earlier encounter of testosterone vs. controls who demonstrated no significant growth in the same time period (Egner et al. 2013) . Further, a similar retention of overload bolstered myonuclei was observed during a subsequent period of denervation induced atrophy (Bruusgaard et al. 2010) . While these studies are suggestive of adaptive physical phenomenon and not necessarily cell programming per se, they suggest that muscle retains a cellular potential following prior growth allowing it to respond to future growth stimuli more quickly and perhaps provide protection from periods of muscle loss.
Conversely, skeletal muscle may also remember periods of catabolic environments. At the cellular level our group was the first to demonstrate that where muscle loss occurs in humans with cancer, muscle cells derived from these patients seem to retain a memory of the environment from which they were isolated. These cells exhibited inappropriate proliferative phenotypes in culture versus aged matched healthy controls (Foulstone et al. 2003) . Recent studies collectively agree with these findings, confirming muscle derived cells do seem to remember their in vivo environment once isolated from different niches such as type II diabetes (Jiang et al. 2013) , obesity (Maples and Brault 2015) , intrauterine growth restriction (Yates et al. 2014 ) and low physical activity levels (Green et al. 2013; Valencia and Spangenburg 2013) .
Although not investigated in the aforementioned studies, the most likely mechanistic underpinning of cellular programming or memory are epigenetic modifications. Epigenetic modifications broadly include histone modifications and DNA methylation that both alter access to enhancer and promoter regions of genes sometimes resulting in altered gene expression. These epigenetic changes have been shown to be transient e.g. methylated for a short period within a cell population following acute environmental stimuli, or extremely stable e.g. being passed to daughter generations of cells, the latter being linked to the concept of cellular programming. Despite its importance, and relevance to muscle adaptability following periods of growth due to hormonal manipulations/ overloading exercise or muscle loss in catabolic disease states; research into the epigenetic regulation of gene expression in skeletal muscle is in its infancy. Currently, more data do however exist regarding the epigenetic control of muscle stem cells and the process of myogenesis (Campos et al. 2013; Dilworth and Blais 2011; Hupkes et al. 2011 ). The muscle specific transcription factor myoD is fundamental in muscle cell lineage determination and for early stages of myoblast differentiation (Blais et al. 2005; Cao et al. 2006 ) via the initiation of p21Cip and irreversible cell cycle exit in G1, a prerequisite for myoblast fusion. MyoD has been shown recently to be bound to a third of gene enhancer regions when a whole genome CHIP assay was performed (Blum et al. 2012) , suggesting an important role for myoD in the epigenetic control of muscle cell growth and regeneration. Our group has further begun to elucidate potential epigenetic modulators of myoblast survival and differentiation (Saini et al. 2012) , where activation of Sirtuin1 (histone deactylase) reduced myoblast death and enabled differentiation in the presence of stress from TNF-a, a cytokine that is chronically up regulated in muscle loss conditions such as sarcopenia and cacheixa. We have extensively shown that TNF-a impairs myoblast fusion/differentiation and myotube hypertrophy with corresponding reductions in myoD gene expression in mouse and human muscle cells (Meadows et al. 2000; Foulstone et al. 2001 Foulstone et al. , 2004 Stewart et al. 2004; AlShanti et al. 2008; Saini et al. 2008; Sharples et al. 2010) . Thus, together with the above studies, this perhaps provides compelling yet preliminary data suggesting that epigenetic mechanisms such as myoD methylation could be involved in TNF-a induced reduction in differentiation and myotube atrophy in muscle cells and potentially be involved in muscle cell programming/memory.
In an attempt to study the impact of catabolic encounters with TNF-a on the ability of skeletal muscle to remember such an encounter, in the present study we aimed to use a novel cellular model that exposed proliferating myoblasts to an early experimental lifespan stimulus of catabolic TNF-a, followed by multiple population doublings (30 doublings similar to methods used in (Sharples et al. 2011 in the absence of TNF-a, prior to the induction of differentiation in the absence or presence of a later second experimental lifespan dose of TNF-a. This model allowed us to elucidate whether muscle cells 'remembered' a prior catabolic stress when they encountered it again during differentiation later in their proliferative lifespan and investigate potential epigenetic modulation of muscle cell memory. We hypothesised that an early experimental life encounter with TNF-a would be 'remembered' by skeletal muscle cells when TNF-a was re-encountered in later proliferative life. Also, this memory would be associated with reductions in differentiation and associated myotube atrophy versus relevant control cells that underwent the same number of replicative divisions in vitro without encountering TNF-a. Further, that this increased susceptibility to TNF-a in the presence of a second, later dose of TNF-a would be associated with altered myoD methylation and subsequent changes in myoD gene expression.
Methods
General cell culture C 2 C 12 mouse skeletal myoblasts (Blau et al. 1985; Yaffe and Saxel 1977) were incubated in T75 flasks in a humidified 5 % CO 2 atmosphere at 37°C in growth medium (GM), composed of: DMEM plus 10 % hi fetal bovine serum, 10 % hi newborn calf serum, 1 % L-glutamine (2 mM final), and 1 % penicillin-streptomycin solution, until 80 % confluence was attained. Differentiation experiments were initiated by washing with PBS, and transferring into Low Serum Media (LSM) composed of: DMEM plus 2 % hi horse serum, 1 % L-glutamine, and 1 % penicillin-streptomycin (both as above) in the absence or presence of TNF-a (20 ngÁml -1 ). A dose extensively characterised by ourselves and others to be an inhibitor of differentiation in mouse and human muscle cells (Foulstone et al. 2001 (Foulstone et al. , 2003 (Foulstone et al. , 2004 (Foulstone et al. , 2010 (Foulstone et al. , 2011 Stewart et al. 2004; Tolosa et al. 2005) . C 2 C 12 cells undergo spontaneous differentiation into myotubes on serum withdrawal, and do not require growth factor addition to stimulate the process (Blau et al. 1985; Tollefsen et al. 1989) .
In-vitro model to assess myoblast programming/ memory: Population doubling and establishing the 'early life' encounter with TNF-a A schematic for deriving the three cell populations (CON, PD, aPD defined below) is depicted in Fig. 1 . Briefly, 10 6 C 2 C 12 cells from the same vial were incubated in a pre-gelatinised T75 flask (0.2 % gelatin, Sigma, UK) in GM for 72 h until approximately 80 % confluent. The cells were washed 9 2 with PBS and trypsinised, counted and split between three new T75's and left to grow for a 24 h in GM before being washed 9 2 with PBS. One flask was transferred to LSM ? TNF-a for 48 h and the other two were transferred to LSM alone. There was no sign differentiation/fusion or dead cells (determined by trypan blue exclusion) during this period. One of the LSM alone flasks was trypsinised, centrifuged, pelleted and re-suspended in GM plus 1 % DMSO in cryovials and frozen in liquid nitrogen to create a stock of control (CON) population cells (i.e. no early experimental life dose of TNF-a and no population doublings vs. other daughter populations below). The other LSM alone flask was also trypsinised and plated back onto new T75's in GM where the cells underwent 10 passages (30 population doublings) after which cells were frozen down as described above to derive the population doubled (PD) cell populations. Finally, in parallel to the PD cells the LSM ? TNF-a T75 flask was also re-plated and transferred back to GM and passaged ten times (30 divisions) where cells were subsequently frozen down to create the 'early life' TNF-a encounter cell type that had also been population doubled (aPD).
Differentiation experiments
The three cell populations (CON, PD, aPD) were brought up from liquid nitrogen. They were plated at 10 6 cellsÁml -1 in separate T75's in GM and incubated in a humidified 5 % CO 2 atmosphere at 37°C for 72 h until 80 % confluent. Cells were collected following trypsinisation, and were counted in the presence of trypan blue dye. All cells (CON, PD and aPD) were seeded at 8 9 10 4 cellsÁml -1 (in 2 ml) in each well of a six well plate and incubated for 24 h in GM. Cells were washed twice with PBS and transferred to 2 ml LSM. well -1 in the absence or presence of TNF-a (20 ngÁml -1 ) for up to 72 h (cell treatments and abbreviations can be seen in Table 1 ). Cells were harvested for counting, total protein and creatine kinase (CK) assays as well as mRNA and DNA for reverse transcription quantitative real time polymerase chain reaction (rt-qRT-PCR) and high resolution melting PCR for gene expression and DNA (CpG) methlyation respectively. Time point zero (DM0) was defined as 30 min subsequent to transferring into DM ± TNFa. Analytical assays described above and detailed below were performed on at least n = 3/4 independent experiments of the derived cell populations with technical replicates being performed for each independent experiment, details of which can be found in the corresponding figure legends where the data is presented.
Assessment of morphological differentiation
Morphological differentiation was assessed using a cell imaging (Leica, DMI 6000 B). All images were obtained at 0 and 72 h following transfer into LSM or TNF-a 20 ngÁml -1
. Myotube number, diameter and area were derived from 72 h images using Image J software (Java soft-ware, National Institutes of Health, USA). Myotube number was counted per image and a global mean ± SD across all images per experimental condition was determined (to avoid including cells undergoing mitosis, a myotube was defined as containing 3
? nuclei encapsulated within cellular structures). For myotube diameter (lm); three widths (equidistantly spaced) were calculated on each myotube and averaged to determine the mean width per myotube. Myotube area (lm 2 ) was determined by tracing around myotube structures using image J 'freehand selection' option. To derive mean myotube diameters and areas per treatment, these assessments were repeated for every myotube per image and a global mean ± SD was calculated across all images per cell treatment. Pixel length was converted to lm using Image J and Leica scaling. Morphological analysis was undertaken on images at 20X magnification. Details of number of images analysed per condition can be found in the specific figure legends.
Total protein and creatine kinase activity (biochemical marker of differentiation) assays Cells were extracted for total protein and CK (creatine kinase) assays at 0 and 72 h. Cells were washed 9 2 in For rt-qRT-PCR experiments cells were lysed in 250 ll/well TRIZOL reagent (Invitrogen Life Technologies, Carlsbad, CA). The RNA was isolated according to manufacturer's instructions and quantified using UV spectroscopy at ODs of 260 and 280 nm, using the Nanodrop spectrophotometer 3000 (Fisher, Rosklide, Denmark). Purity of samples was assessed by 260:280 nm ratio's that ensured end values between 1.9 and 2.15. Identification of primer sequences (see below) was enabled by Gene (NCBI, www.ncbi.nlm.nih.gov/gene) and designed using OligoPerfectTM Designer (Invitrogen, Carlsbad, CA, USA) and/or Primer-BLAST (NCBI, http://www. ncbi.nlm.nih.gov/tools/primer-blast). Primers were purchased from Sigma (Suffolk, UK). Sequence homology (BLAST) searches ensured the primers only matched the intended sequence and therefore gene that they were designed for. Primers were made to exclude self-dimer, hairpins and cross-dimers. All primers designed were between 18 and 23 bp and the GC content ranged between 43 and 50 %. rt-qRT-PCR was carried out using QuantiFast TM SYBR Ò Green RT-PCR one-step kit on a Rotogene 3000Q (Qiagen, Crawley, UK) supported by Rotogene software (Hercules, CA, USA). Reverse transcription was performed on the isolated mRNA at 50°C (for 10 min), followed by 5 min 95°C (transcriptase inactivation and initial denaturation), followed by: 10 s, 95°C (denaturation), 30 s, 60°C (annealing and extension) for 40 cycles. At the end of the cycling, melt curve analysis (50-99°C at 1°C increments) allowed identification of nonspecific amplification or primer-dimer issues, none were apparent for the primer sequences listed in above methods. All PCR efficiencies were comparable (93.04 ± 4.32 %) across all conditions and genes. Relative mRNA expression was quantified for myoD using the comparative Ct ( DDCt ) method (Schmittgen and Livak, 2008 ) against a stable reference gene of RPIIb (polr2b) (combined Ct value across experimental conditions 16.05 ± 0.31) and calibrator of CON cells in LSM at 0 h.
DNA isolation
Cells were washed 9 2 in PBS (2 ml well -1 ) and incubated for 1.5 h at 37°C in 250-300 ll of sterile filtered DNA lysis buffer: 1.5 M Tris pH 8.8, (Sigma T1503), 0.25 M EDTA (Sigma E5134), 4 M NaCl, 0.02 % TritonX-100, and 100 lg ml -1 Proteinase K (Sigma P4850). The wells were scraped and cell lysate collected and centrifuged 14,000 rpm at room temperature for 5 min. The supernatant was collected (contains DNA) and an equal volume of isopropanol/ NaCl (100 mM) was added and incubated overnight at -20°C. The sample was next centrifuged for 20 min at 14,000 rpm, the supernatant removed and the DNA pellet reconstituted in TE, pH 8 supplemented with RNase (Ribonuclease A, 10 mg ml -1) and incubated for 1 h at 37°C before being vortexed and stored for downstream applications at -80°C. DNA was bisulfite converted (Epitect Bisulfite conversion kits, Qiagen, Manchester, UK) according to manufacturer's instructions and quantified using UV spectroscopy (Nanodrop spectrophotometer 3000, Fisher, Rosklide, Denmark) using the single stranded DNA conversion factor (at 260 nM the coefficient of extinction for single-stranded DNA is 0.027 lg ml -1 cm -1 , thus, an OD of 1 corresponds to a concentration of 33 lg ml -1 for single-stranded DNA). Once bisulfite converted, DNA was stored in -80°C in Qiagen's elution buffer until required for HRM PCR (below). All primers designed amplified a product between 119 and 214 bp. PCR cycles were as follows: 10 s, 95°C (denaturation), 30 s, 55°C (annealing) 10 s, 72°C extension for a maximum of 55 cycles. Following PCR a high resolution melt (HRM) protocol was undertaken on the PCR products where the products were melted at 0.1°C increments from 65 to 95°C. This gave high resolution melt curves for fluorescence (y axis) versus melt temperature (x axis). A standard curve using the melt analysis was created using methylated mouse DNA standard controls (100, 75, 50, 25, 10, 5, 0 % methylated; EpigenDX, MA, USA) that also underwent the same bisulfite conversion as experimental samples, PCR and HRM as described above (this included a 100 % methylated control sample that had not been bisulfite converted to act as a negative control). All samples were run in duplicate. Duplicate samples were normalised to 0 % methylated controls and averaged to produce a single curve (Fig. 3a) . The relationship between the area under the curve, determined from integration of each standard curve, and the corresponding percentage of methylation was defined via the best fitting fourth-order polynomial relation (Fig. 3b) . The correlation coefficients we obtained were typically high r B 0.98 and indicate high precision across the full percentage range. This calibrated relationship was used to quantify the % methylation from the integrated raw melt curves of experimental samples. The percentages were normalised to CON LSM 0 h conditions to indicate fold change in percentage methylation. These calculations were performed using a bespoke Python-based program, MethylCal (T. M. Hughes).
Statistical analyses
Statistical analyses and the significance of the data were determined using minitab version 17.0. Results are presented as mean ± standard deviation (SD). Data were scanned for potential outliers using stem and leaf plots and all data was deemed to be normally distributed and satisfy homogeneity of variance tests. Statistical significance for interactions between cell type (CON, PD, aPD) and dose (DM, TNF-a 20 ngÁml -1 ) at 72 h was determined using (3 9 2) mixed two-way Factorial ANOVA for all dependant variables (CK, myotube number/diameter/area, myoD transcript expression, and myoD 01,02,03,04 and pooled CpG island methylation. Bonferroni and Tukey post hoc tests were conducted for all pairwise comparisons (unless otherwise stated in the text and as detailed in the figure legends). If Bonferroni pairwise comparisons were not significant and Tukey significant then this was detailed in the figure legends. For all statistical analyses, significance was accepted at P B 0.05.
Results

Morphological/biochemical differentiation and myotube hypertrophy
Basally, 30 population doublings alone (PD) cells demonstrated a significant reduction in differentiation and myotube hypertrophy vs. CON cells (Fig. 2a) ; where biochemical differentiation/CK activity (PD 345.2 ± 48.4 vs. CON 445.1 ± 60.6 mUÁmgÁml -1 ; P B 0.05; Fig. 2b ), myotube number (PD 2.78 ± 0.833 vs. CON 3.46 ± 0.519; P B 0.05; Fig. 2c ) and myotube area (PD 9335 ± 2468 vs. CON 13,677 ± 2395 lm 2 ; P B 0.05; Fig. 3e ) were significantly reduced, yet myotube diameter unchanged (Fig. 2d) . Interestingly, an early experimental life dose of TNF-a followed by 30 population doublings (aPD) was unable to reduce differentiation significantly vs. PD cells alone (myotube number: aPD 2.77 ± 0.439 vs. PD 2.78 ± 0.83; diameter: aPD 21.97 ± 1.67 vs. PD 22.74 ± 2.22 lm, area: aPD 7047 ± 1976 vs. PD 9335 ± 2468 lm 2 ; P = NS; Fig. 2c, d , e respectively) suggesting no impact of an 'early life' encounter with TNF-a after 30 population doublings versus the relevant PD control, at least when cells are induced to differentiate under basal (LSM alone, i.e. no TNF-a) conditions. TNF-a reduced differentiation (CK and myotube number) and myotube area in CON cells (CK: CON 445.1 ± 60.6 vs. CONa 237.9 ± 47.2 mUÁmgÁml -1 ; myotube number: CON 3.46 ± 0.519 vs. CONa 2.615 ± 0.519; area: CON 13,677 ± 2395 vs. CONa 9577 ± 1924 lm 2 ; all P B 0.05; Fig. 2b , c, e respectively). Similarly, TNF-a significantly reduced biochemical differentiation in PD cells versus their own basal control (CK: PD 345.2 ± 48.4 vs. PDa 231.5 ± 29.6 mU mg ml -1 , P B 0.05; Fig. 2b ) where there were also average, yet non-significant reductions in morphological analysis of differentiation and hypertrophy (myotube number: PD 2.78 ± 0.83 vs. PDa 2.0 ± 0.54; diameter: PD 22.74 ± 2.22 vs. PDa 20.3 ± 1.66 lm, P = N.S. Fig. 2c, d ). Despite lack of significance on the latter parameters, there were larger absolute reductions in differentiation (myotube number) and hypertrophy (myotube diameter) observed in PD cells with TNF-a administration that resulted in significant differences vs. CON cells in the presence of TNF-a (myotube number: PDa 2.0 ± 0.54 vs. CONa 2.615 ± 0.519; diameter: PDa 20.31 ± 1.66 vs. CONa 22.9 ± 2.35 lm; all P B 0.05, Fig. 2c , d respectively), with again average but non-significant reductions in myotube area (PDa 7224 ± 2847 vs. CONa 9577 ± 1924 lm 2 , P = N.S; Fig. 2e) .
Importantly, the largest average absolute reductions in differentiation were in cells that had received an early proliferative lifespan encounter with inflammatory cytokine TNF-a and undergone subsequent 30 population doublings and then encountered a later life cytokine challenge during differentiation (aPDa cell population) vs. PD cells without the early encounter with TNF-a, but differentiated in the presence of TNFa (PDa) (myotube number aPDa 1.54 ± 0.52 vs. PDa 2.0 ± 0.54, diameter aPDa 18.93 ± 1.8 vs. PDa 20.31 ± 1.66, area aPDa 6022 ± 1038 vs. PDa 7224 ± 2847, P = N.S.; Fig. 2c, d , e respectively), where differences in biochemical differentiation (CK activity) resulted in significance (aPDa 165.5 ± 19.81 vs. PDa 231.5 ± 29.6 mUÁmgÁml -1 , P B 0.05; Fig. 2b) . Overall, the results above lead to significant interactions between dose and cell type for CK activity and myotube area (both P B 0.05). The cells that had received an early experimental life encounter with TNF-a, retained a memory, at least with respect to differentiation, when they encountered an inflammatory catabolic stress was experienced again during later life differentiation, where these cells showed the lowest average absolute reductions in all parameters versus all other conditions.
MyoD CpG methylation
We next wished to assess the role of CpG island methylation of myoD to evaluate the impact of potential hypo/hypermethylation on corresponding increases or decreases respectively in myoD gene expression (see below). The largest fold increases in methylation above baseline were in cells exposed to the early encounter with TNF-a, expanded over 30 doublings before being cultured in LSM and induced to differentiate versus their relevant controls (PD). This held true across all CpG islands studied (Fig. 3c-g ). When analysed further, there was a significant main effect for cell type for all CpG islands investigated (myoD 01: P = 0.05, Fig. 3c ; myoD02: P = 0.002, Fig. 3d ; myoD03: P = 0.035, Fig. 3e ; myoD 04: P = 0.006, Fig. 3f ). When relative fold changes were pooled across all CpG assays (Fig. 3g) there was a significant main effect for cell type (P B 0.001), dose (P = 0.003) and a significant interaction for cell type 9 dose (P = 0.012). Specifically, there was a significant pairwise comparisons for aPD versus CON and aPDa versus PD for CpG island myoD02 (aPD 1.61 ± 0.07 vs. CON 1.25 ± 0.02, P B 0.05 and aPDa 1.5 ± 0.07 vs. PD 1.35 ± 0.07, P B 0.05) and aPD versus PD for CpG island myoD04 (aPD 2.06 ± 0.03 vs. PD 1.36 ± 0.07, P B 0.05). There were also significant pairwise comparisons (Fisher LSD) between aPD versus PD for CpG island myoDo1 (aPD 1.55 ± 0.27 vs. PD 1.3 ± 0.15 and CON 1.23 ± 0.1, P B 0.05), aPD versus PD and CON for CpG island myoD02 (aPD 1.61 ± 0.07 vs. PD 1.35 ± 0.07 and CON 1.25 ± 0.02, P B 0.05), myoDo3 (aPD 2.32 ± 0.21 vs. PD 1.54 ± 0.07 and CON 1.61 ± 0.2, P B 0.05) and myoD04 (aPD 2.06 ± 0.03 vs. PD 1.36 ± 0.07 vs. CON 1.44 ± 0.03, P B 0.05). Importantly, when relative fold change data were pooled across CpG assays (Fig. 3g) there was also a significant pairwise comparisons for aPD vs. PD and CON (aPD 1.89 ± 0.36 vs. PD 1.39 ± 0.12 and vs. CON 1.38 ± 0.12, P B 0.05), suggesting that an acute early experimental life encounter with TNF-a alone is powerful enough to be conserved through 30 population doublings and remain elevated in basal LSM.
Although methylation did not increase further in cells that had experienced an early experimental life encounter with TNF-a and then received a second TNF-a encounter upon differentiation (aPDa), the higher mean levels in aPD were sustained in this condition in myoD01, 02 and 04 (actually reduced for myoD03, yet was not significant) evident by no significant differences with aPD for all CpG islands analysed (all aPDa vs. PDa comparisons, P = N.S.). After pooling all CpG fold changes there was indeed significantly reduced methylation in aPDa conditions vs. aPD (aPDa 1.52 ± 0.13 vs. aPD 1.89 ± 0.36), however, aPDa vs. PDa or PD alone were not significantly different.
MyoD gene expression changes
In the present study TNF-a reduced myoD expression in all cell types resulting in a significant main effect for dose (LSM pooled mean 2.179 vs. TNF-a pooled mean 1.01, P B 0.001 ; Fig. 4) ; with significant post hoc comparisons in for LSM control versus TNF-a dosed (CON 2.7 ± 0.57 vs. CON a 1.15 ± 0.55, P B 0.05; PD 1.84 ± 0.34 vs. PDa 0.86 ± 0.47, P B 0.05; aPD 1.91 ± 0.31 vs. aPDa 0.87 ± 0.26, P B 0.05). Furthermore, there was also a significant main effect for cell type (P = 0.028) suggesting that myoD expression was reduced to the greatest extent in the PD and aPD cells versus CON regardless of dose (aPD 1.39, PD 1.35 vs. CON 1.93) . Further, TNF-a administration during differentiation resulted in the largest average reductions were in both PD and aPD cell types resulting in a significant difference vs. PD LSM for both cell types (PDa 0.86 ± 0.47 and aPDa 1.032 ± 0.42 vs. PD 1.85 ± 0.34; P B 0.05). Although cells that had undergone an early stimulus with TNF-a, undergone multiple population doublings and received a subsequent dose upon serum withdrawal and differentiation (aPDa cells) exhibited reductions in differentiation, myoD however, was also comparably reduced in PD cells in the presence of TNF-a (PDa 0.86 ± 0.47 and aPDa 1.032 ± 0.42, P = N.S.).
Discussion
The present study demonstrates for the first time that muscle cells exposed to an early experimental life (pre-population doubling) dose of TNF-a (aPD cells) were more susceptible to a subsequent post-population doubling encounter with the same cytokine. The cytokine induced larger absolute reductions in morphological/biochemical differentiation versus relevant non-treated, population doubled control cells. We also present novel findings suggesting that these cells retain increased methylation of myoD following their early experimental 'life' proliferative encounter with TNF-a and retain these hypermethlyated patterns even after a subsequent 30 population doublings. Despite methylation remaining higher with the second later life TNF-a stimulus versus PD alone, it was not further elevated versus cells that received TNF-a at an early proliferative stage alone. This suggested, in opposition to the original hypothesis, that despite an increased susceptibility to reductions in differentiation and associated myotube atrophy in the cells that received an early plus later life dose of TNF-a, myoD methylation does not seem to be driving this morphological response. Furthermore, in disagreement with the original hypothesis, myoD hypermethylation in these cells did not correspond with reductions in myoD gene expression that appeared to be the same in the cells that had received the early experimental life encounter of TNF-a (aPD cells) versus population doubled (PD) alone cells. Finally, myoD gene expression for both population doubled alone cells (PD) versus those that had received an early experimental life dose of TNF-a and subsequently population doubled (aPD) were not further impaired in the presence of TNF-a during differentiation. Therefore, despite showing that cells that encounter an acute early life insult of TNF-a seem to have increased methylated CpG regions, myoD expression per se may not be the main driver of reduced differentiation observed when these cells encountered a second later life TNF-a insult. We also observed a similar trend to that of myoD for both myogenin and IGF-I gene expression (data not shown) suggesting that MRF's or IGF-I family members were also not the main driver of TNF-a induced reductions in differentiation, which therefore may be hypothesised to come as a result of altered cellular signalling processes e.g. via p38 MAPK phosphorylation as its activity has been previously suggested to be heavily involved in TNFa induced impairments in differentiation (Chen et al. 2007 ). However, this requires future investigation as to its role in potential morphological memory observed in the present study. It could also be further hypothesised that after early experimental life doses of inflammatory cytokines, subpopulations of cells may become quiescent once the environmental stress has ceased, harbouring epigenetic alterations that could be preserved over many daughter populations. Therefore, these are the cells that retain altered methylated regions while muscle cell function maybe somewhat preserved in the majority of the population. This is certainly warrants further investigation in the present in vitro model. Overall, however, we present novel findings that suggest upon administration of a cytokine in early proliferative life, muscle cells increase and retain these hypermethylated regions even after subsequent 30 population doublings. Despite epigenetic mechanisms seemingly not underpinning the worsened biochemical and morphological differentiation following a later life exposure to TNF-a, there never the less appears to be a preservation of epigenetic status in muscle cells following an acute cytokine stress. Future large scale methylome studies to identify CpG islands associating in cis (mapping to gene location) are required in this model to investigate the potential impact of TNF-a on CpG methylation acutely and over time in skeletal muscle cells. These pertinent studies would identify CpG islands across all genes and how/if these regulate the impaired differentiation and myotube hypertrophy experienced in muscle cells that have had early life cytokine encounters.
A so called 'memory' as a concept has been recently alluded to whereby 3 months of testosterone administration in mice enabled muscle growth accompanied by increased myonuclei numbers that, interestingly, were retained during subsequent testosterone withdrawal despite muscle size losses. Most importantly, the subsequent rate of growth response following mechanical overload (resistance exercise) was a 31 % increase in muscle cross-sectional area in the animals that had received an earlier encounter of testosterone (Egner et al. 2013 ) versus control animals. This accompanied earlier work by the same group that suggested myonuclei acquired by mechanical overload are retained during a subsequent atrophic event (Bruusgaard et al. 2010) . While this is an adaptive physical phenomenon and not necessarily cell programming per se, these studies importantly suggest that muscle retains a cellular potential following prior growth allowing it to respond to future growth stimuli more quickly, importantly allowing protection during subsequent periods of muscle loss. In the present study we were investigating differentiation and myotube hypertrophy following a catabolic stress, not the role of prior fused myonuclei following a hypertrophic stimulus. However, the present in vitro model could easily be manipulated to investigate the impact on established myotubes with a hypertrophic stimulus from testosterone, IGF-I or even exercise stimuli via mechanical stretch or electrical stimulation in vitro in monoloayer or using three dimensional bioengineered skeletal muscle e.g. (Player et al., 2014) . It is worth noting that there are limited studies assessing DNA methylation post exercise particularly with respect to a memory of earlier exercise or nutritional encounters. Notably, a recent study in skeletal muscle, demonstrated acute metabolic stress (aerobic exercise) reduces DNA methylation of enhancer regions (hypomethlyation) of genes associated with mitochondrial biogenesis (PGC-1a, PDK4 and PPAR-d) that presumably in turn allowed increased promoter activity (although not directly investigated) and thus increased corresponding transcript expression (Barres et al. 2012) . Similarly a more recent study suggests that acute nutritional manipulation (fasting) in combination with acute exercise also provides evidence of an inverse relationship with DNA methylation and gene expression of important metabolic genes involved in substrate utilization (Lane et al. 2015) . However, adaptation in the terms of stable methylation patters after chronic anabolic exercise stimuli or periods of catabolic injury/disuse remains unstudied, as do methylation of genes that control muscle mass.
Our groups' earlier work has shown that human muscle cells derived from negative environment such cancer patients remember the environment from which they were derived where they actually exhibited inappropriate proliferative phenotypes versus aged matched healthy controls (Foulstone et al. 2003) . More recently this concept has been confirmed and discussed by four further papers (three original works, one review). They collectively suggest muscle derived cells retain a memory once isolated from different environmental niches: (1) muscle derived cells from humans who are physically active, display an improved ability to uptake glucose and are somewhat protected from palmitate induced insulin resistance versus cells isolated from sedentary humans (Green et al. 2013; Valencia and Spangenburg 2013) ; (2) muscle derived cells from obese patients do not respond to lipid oversupply with the same gene expression signatures versus control (Maples and Brault 2015) ; (3) muscle derived cells from intrauterine growth-restricted sheep fetuses exhibit deficiencies in proliferation versus controls (Yates et al. 2014) . Importantly all of these studies, highlight that muscle derived stem cells with mitotic potential could be important in the concept of programming/memory in skeletal muscle tissue. The latter is particularly pertinent given a recent in vivo study suggesting protein restriction in maternal rats results in what the authors termed 'metabolic inflexibility' in the resulting offsprings skeletal muscle; where impaired expression of genes that increase the capacity for fat oxidation in response to fasting was observed (Aragao et al. 2014) . Given that malnutrition during pregnancy is also associated with the progression of sarcopenia into old age in humans, the mechanisms of muscle memory of negative encounters is a particularly pertinent avenue for future research. The only study, other than the data in this manuscript, to investigate potential epigenetic modulation of cell memory from negative environmental encounters was in a recent study where lipid oversupply in obese patients muscle derived cells possessed increased DNA methylation of PPARd with subsequent larger reductions in PPARd gene expression vs. non obese controls (Maples and Brault 2015) . Despite the subjects in the control group not being age matched with the obese group, where the obese group were on average almost 7 years older, this study, together with present results, implies that epigenetics could be important in muscle memory and impact on skeletal muscle adaptation and function during negative environmental encounters.
In summary: This study showed that skeletal muscle cells have increased susceptibility in late proliferative life to TNF-a stress when the cells have experienced an earlier, acute TNF-a encounter. This is suggestive of a morphological memory of catabolic stress in myoblasts. Importantly, muscle cells that have experienced even an acute cytokine stress in early life possess an elevated myoD methylation status that is retained into later proliferative lifespan. Despite this, there were no further increases in myoD methylation or gene expression when these cells experienced a further cytokine stress in later life, suggesting that in this model and at the times points studied, epigenetic control of myoD gene expression was not driving the observed morphological memory of increased susceptibility to TNF-a. It remains to be seen if these observations can be recapitulated in vivo especially when satellite cells are so efficient at proliferating and regenerating muscle, even with age (e.g. Collins et al. 2005 Collins et al. , 2007 . This study does however suggest an important potential epigenetic mechanism via retention of DNA methylation throughout proliferative lifespan in muscle cells following inflammatory stress that is potentially associated with muscle loss into old age of humans.
